These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The differential diagnosis of anxiety. Psychiatric and medical disorders. Cameron OG Psychiatr Clin North Am; 1985 Mar; 8(1):3-23. PubMed ID: 3887337 [TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097 [TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. Charney DS; Woods SW J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo]. Lemoine P; Touchon J; Billardon M Encephale; 1997; 23(4):290-9. PubMed ID: 9417395 [TBL] [Abstract][Full Text] [Related]
6. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment. Mercier-Guyon C; Chabannes JP; Saviuc P Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182 [TBL] [Abstract][Full Text] [Related]
10. [Panic disorder and panic attack]. Abbar M Encephale; 1996 Dec; 22 Spec No 5():13-8. PubMed ID: 9138941 [TBL] [Abstract][Full Text] [Related]
11. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. Chouinard G J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
13. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome. Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418 [TBL] [Abstract][Full Text] [Related]
15. [Benzodiazepines in the treatment of anxiety. The risks and alternatives]. Trucco M Rev Med Chil; 1990 Nov; 118(11):1262-70. PubMed ID: 1983806 [TBL] [Abstract][Full Text] [Related]
16. [The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms]. Kornowski J Psychiatr Pol; 2002; 36(6 Suppl):311-8. PubMed ID: 12647454 [TBL] [Abstract][Full Text] [Related]
17. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience. Tesar GE J Clin Psychiatry; 1990 May; 51 Suppl():4-10; discussion 50-3. PubMed ID: 1970816 [TBL] [Abstract][Full Text] [Related]
18. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Bhanji NH; Chouinard G; Kolivakis T; Margolese HC Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219 [TBL] [Abstract][Full Text] [Related]